Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
20,248,444
-
Share change
-
+1,108,806
-
Total reported value
-
$191,350,000
-
Price per share
-
$9.45
-
Number of holders
-
38
-
Value change
-
+$11,483,446
-
Number of buys
-
21
-
Number of sells
-
18
Institutional Holders of AC Immune SA - SHS (ACIU) as of Q4 2018
As of 31 Dec 2018,
AC Immune SA - SHS (ACIU) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,248,444 shares.
The largest 10 holders included
FMR LLC, Temasek Holdings (Private) Ltd, Duquesne Family Office LLC, BVF INC/IL, JANUS HENDERSON GROUP PLC, ORBIMED ADVISORS LLC, Artal Group S.A., MARSHALL WACE, LLP, BlackRock Inc., and CITADEL ADVISORS LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.